Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene

Leukemia Research

Volumn 36, Issue 3, 2012, Pages 377-381

  Mayeur Rousse, Caroline ^a,b,c   Sorel, Nathalie ^c,d   Voldoire, Maud ^d   Canioni, Danielle ^e   Brizard, Françoise ^d   Randriamalala, Edouard ^d   Turhan, Ali G ^c,d   Chomel, Jean Claude ^c,d  

^a HÔPITAL PAUL BROUSSE   (France)

^b BICÊTRE HOSPITAL   (France)

^c Centre National de la Recherche Scientifique   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; IDARUBICIN; LACTATE DEHYDROGENASE; MITOXANTRONE;

ADULT; ARTICLE; BLAST CELL CRISIS; BONE MARROW BIOPSY; CASE REPORT; CYTOGENETICS; DISEASE ASSOCIATION; EOSINOPHILIA; FGFR1 GENE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; LYMPHADENOPATHY; MALE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NEUTROPHILIA; NORMOCHROMIC NORMOCYTIC ANEMIA; PAIN; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; THROMBOCYTOPENIA; WEAKNESS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLAST CRISIS; CYTARABINE; DNA-BINDING PROTEINS; FATAL OUTCOME; GENE REARRANGEMENT; HUMANS; IDARUBICIN; MALE; MASTOCYTOSIS, SYSTEMIC; MYELOPROLIFERATIVE DISORDERS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TRANSCRIPTION FACTORS;

EID: 84855957112     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.10.009     Document Type: Article

References (15)

1. Valent P., Horny H.P., Escribano L., Longley B.J., Li C.Y., Schwartz L.B., et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leukemia Research 2001, 25:603-625.
2. Horny H.P., Metcalfe D.D., Bennett J.M., Bain B.J., Akin C., Escribano L., et al. Mastocytosis. World Health Organization (WHO) classification of tumours of haematopoietic and lymphoid tissues 2008, 55-63. IARC Press, Lyon, France. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
3. Valent P., Horny H.P., Li C.Y., Longley B.J., Metcalfe D.D., Parwaresch R.M., et al. Mastocytosis. World Health Organization (WHO) classification of tumours of haematopoietic and lymphoid tissues 2001, 291-302. IARC Press, Lyon, France. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (Eds.).
4. Pardanani A., Lim K.H., Lasho T.L., Finke C., McClure R.F., Li C.Y., et al. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with others myeloid malignancies. Blood 2009, 114:3769-3772.
5. Sotlar K., Colak S., Bache A., Berezowska S., Krokowski M., Bültmann B., et al. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD). Journal of Pathology 2010, 220:586-595.
6. Travis W.D., Li C.Y., Yam L.T., Bergstralh E.J., Swee R.G. Significance of systemic mast cell disease with associated hematologic disorders. Cancer 1988, 62:965-972.
7. Horny H.P., Sotlar K., Sperr W.R., Valent P. Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. Journal of Clinical Pathology 2004, 57:604-608.
8. Agis H., Sotlar K., Valent P., Horny H.P. Ph-chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis. Leukemia Research 2005, 29:1227-1232.
9. Lim K.H., Tefferi A., Lasho T.L., Finke C., Patnaik M., Butterfield J.H., et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009, 113:5727-5736.
10. Patnaik M., Gangat N., Knudson R.A., Keefe J.G., Hanson C.A., Pardanani A., et al. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution. American Journal of Hematology 2010, 85:238-242.
11. Bain B.J. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. Haematologica 2010, 95:696-698.
12. Goradia A., Bayer M., Cornfield D. The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report. International Journal of Clinical and Experimental Pathology 2008, 1:448-456.
13. Yavuz A.S., Lipsky P.E., Yavuz S., Metcalfe D.D., Akin C. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. Blood 2002, 100:661-665.
14. Garcia-Montero A.C., Jara-Aceveldo M., Teodosio C., Sanchez M.L., Nunez R., Prados A., et al. KIT mutation in mast cell and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish network on mastocytosis (REMA) in a series of 113 patients. Blood 2006, 108:2366-2372.
15. Kim Y., Weiss L.M., Chen Y.-Y., Pullarkat V. Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma. Leukemia Research 2007, 31:1749-1754.